Apollo Global Management Acquires Minority Stake in Swiss Dental Medtech Company vVardis

MT Newswires Live04-27 19:58

Apollo Global Management (APO) has made a strategic minority investment in dental medical technology firm vVardis, the Swiss company said Monday.

"The investment establishes vVardis as one of Europe's few privately owned, billion-dollar-plus, healthcare companies," vVardis said.

The investment will support global expansion of the company's Curodont platform, a non-invasive early tooth decay treatment, as its scales commercialization across the US and Europe, vVardis said.

Founders and co-chief executives Haley Abivardi and Goly Abivardi will retain a substantial majority shareholding after the transaction, the company said.

Financial terms of the transaction were not disclosed.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment